Share of people with HIV who receive antiretroviral therapy in Kazakhstan
Kazakhstan: Share of people with HIV who receive antiretroviral therapy was 74.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Kazakhstan, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
Kazakhstan recorded 74.0% for share of people with hiv who receive antiretroviral therapy in 2024. That is the highest value across all 25 years on record.
The figure is up 5.7% on the previous year and up 270.0% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Kazakhstan peaked at 74.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Kazakhstan 66th out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Kazakhstan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 3.0% | — |
| 2006 | 3.0% | +0.0% |
| 2007 | 4.0% | +33.3% |
| 2008 | 5.0% | +25.0% |
| 2009 | 7.0% | +40.0% |
| 2010 | 8.0% | +14.3% |
| 2011 | 10.0% | +25.0% |
| 2012 | 13.0% | +30.0% |
| 2013 | 17.0% | +30.8% |
| 2014 | 20.0% | +17.6% |
| 2015 | 24.0% | +20.0% |
| 2016 | 28.0% | +16.7% |
| 2017 | 38.0% | +35.7% |
| 2018 | 47.0% | +23.7% |
| 2019 | 52.0% | +10.6% |
| 2020 | 56.0% | +7.7% |
| 2021 | 60.0% | +7.1% |
| 2022 | 65.0% | +8.3% |
| 2023 | 70.0% | +7.7% |
| 2024 | 74.0% | +5.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.2% | 0.0% | 7.0% | 10 |
| 2010s | 25.7% | 8.0% | 52.0% | 10 |
| 2020s | 65.0% | 56.0% | 74.0% | 5 |
Countries ranked near Kazakhstan
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Population ages 50-54, male, annual growth rate 1.78 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0249 units per person (2025)
- Population ages 55-59, female, annual growth rate 0.032 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0258 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Kazakhstan?
- Share of people with hiv who receive antiretroviral therapy in Kazakhstan was 74.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Kazakhstan?
- The highest recorded value was 74.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Kazakhstan?
- The lowest recorded value was 0.0% in 2000.
- How does Kazakhstan rank for share of people with hiv who receive antiretroviral therapy?
- Kazakhstan ranks 66th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Kazakhstan?
- Over the last ten years it is up 270.0%. The long-run trend across the full record is volatile.
- Where does this Kazakhstan data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.